ℹ️
🇬🇧
Search
Search for publications relevant for "DPP-4"
DPP-4
Publication
Class
Person
Publication
Programmes
Export current view
publication
Clinical use of DPP-4 inhibitors
2012 |
Second Faculty of Medicine
publication
Inhibitors of DPP-4 and cardiovascular effects
2016 |
Faculty of Medicine in Pilsen
publication
Comparison of clinical efficacy of DPP-4 inhibitors sitagliptin and vildagliptin
2009 |
Second Faculty of Medicine
publication
DPP-4 inhibitors and autoimmunity
2014 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Selectivity of DPP-4 inhibitors and heart failure
2016 |
First Faculty of Medicine
publication
Cardioascular effect of incretin-based therapies: comparison od DPP-4 inhibitors and GLP-1 agonists
2014 |
First Faculty of Medicine
publication
Update on therapy with dipeptidyl-peptidase 4 inhibitors
2014 |
Second Faculty of Medicine
publication
Sitagliptin in 2012 - the current knowledge about the first DPP-4 inhibitor
2012 |
Second Faculty of Medicine
publication
Inhibitory DPP-4-gliptins: clinical practice 2010
2011 |
Second Faculty of Medicine
publication
Modern treatment of diabetes in questions and responses
2014 |
First Faculty of Medicine
publication
Inhibitory DPP-4 a kardiovaskulární nežádoucí účinky
2017 |
Publication without faculty affiliation
publication
Inhibitory DPP-4 a agonisté receptoru pro GLP-1 se nevzdávají
2018 |
Second Faculty of Medicine
publication
Linagliptin in the treatment of type 2 diabetes mellitus current status and perspectives
2013 |
First Faculty of Medicine
publication
KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors
2017 |
Second Faculty of Medicine
publication
Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria
2013 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Sitagliptin - first inhibitor of DPP-4
2011 |
Second Faculty of Medicine
publication
Basic pharmacology of dipeptidyl peptidase-4 (DPP-4) inhibitors
2015 |
Third Faculty of Medicine
publication
Linagliptin in the therapy of diabetes mellitus in 2012 - novelties and perspectives
2012 |
First Faculty of Medicine
publication
CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle
2019 |
First Faculty of Medicine
publication
Fixed combination of linagliptin/metformin in the treatment of type 2 diabetes mellitus
2013 |
First Faculty of Medicine
publication
Efficiency and safety of linagliptin - relevance to clinical practice
2014 |
First Faculty of Medicine
publication
Gliptins and diabetes treatment - today and in the future
2011 |
Faculty of Medicine in Hradec Králové
publication
New possibilities of vildagliptin administration as part of combinations of three drugs
2013 |
First Faculty of Medicine
publication
The benefit of gliptin therapy in elderly diabetics
2022 |
Publication without faculty affiliation
publication
The effect of newer antidiabetic drugs on the weight of patients with type 2 diabetes
2010 |
First Faculty of Medicine
publication
Commentary - Saxagliptine is non-inferior to gipizide in partients with type 2 diabetes mellitus
2011 |
First Faculty of Medicine
publication
How will diabetes treatment change with new pharmaceuticals?
2015 |
Second Faculty of Medicine
publication
Approach focused on the patient - the path to true individualization of diabetes
2012 |
First Faculty of Medicine
publication
Sitagliptin is safe alternative in the treatment of the light renal insuficiency
2008 |
Second Faculty of Medicine
publication
Vildagliptin/metformin fixed-dose combination
2009 |
First Faculty of Medicine